BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 5847732)

  • 1. [Characterization study of the autoantigenic reaction between serum and spleen in rats].
    Dufour D; Tremblay A
    Bull Assoc Fr Etud Cancer; 1965; 52(2):179-84. PubMed ID: 5847732
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of the tumour transplantation immunity by the local graft-versus-host reaction.
    Medzihradský J
    Neoplasma; 1967; 14(4):369-75. PubMed ID: 6063011
    [No Abstract]   [Full Text] [Related]  

  • 3. Supression of species resistance in mice to rat tumor (Walker 256 carcinosarcoma) by rat thymus antiserum.
    Anigstein L; Anigstein DM; Rennels EG
    Tex Rep Biol Med; 1967; 25(2):214-22. PubMed ID: 6035439
    [No Abstract]   [Full Text] [Related]  

  • 4. The isolation, characterization, and antigenicity of malignolipin-like material from normal and tumor tissue.
    Petering HG; Van Giessen GJ; Buskirk HH; Crim JA; Evans JS; Musser EA
    Cancer Res; 1967 Jan; 27(1):7-14. PubMed ID: 6020367
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification of tumor homograft immunity during the graft-versus-host reaction.
    Medzihradský J
    Neoplasma; 1966; 13(2):223-6. PubMed ID: 5911878
    [No Abstract]   [Full Text] [Related]  

  • 6. [On defined tumor-tolerant and tumor-resistant strains of CFN rats. (Genetic and immunobiological problems in the transplantation of Walker-256 carcinosarcoma in various homologous hosts)].
    Lehmann FE; Meyer V
    Arch Julius Klaus Stift Vererbungsforsch Sozialanthropol Rassenhyg; 1963; 38(3-4):242-52. PubMed ID: 5899906
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal lesions associated with the Walker 256 adenocarcinoma in the rat.
    Dinh BL; Brassard A
    Br J Exp Pathol; 1968 Apr; 49(2):145-51. PubMed ID: 4967169
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of spleen on immune function of rats with liver cancer complicated by liver cirrhosis.
    Yao YM; Liu QG; Yang W; Zhang M; Ma QY; Pan CE
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):242-6. PubMed ID: 14599977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic behavior of Walker 256 tumor in Sprague-Dawley rats.
    Buinauskas P; Brown ER; Cole WH
    Surgery; 1966 Oct; 60(4):902-7. PubMed ID: 5921635
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor immunity following cauterization.
    Rosen RG; Gardner B; Reiter B
    Surg Forum; 1968; 19():94-5. PubMed ID: 5718435
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relations between tumor growth and immunity].
    Keller R
    Schweiz Med Wochenschr; 1972 Aug; 102(33):1148-51. PubMed ID: 5055034
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of various dietary fatty acids on enzyme activities of carbohydrate and glutamine metabolism and the metabolic response of lymphocytes and macrophages during Walker-256 ascites cell tumour growth in rats.
    Rosa LF; Guimaraes AR; Safi DA; Curi R; Williams JF
    Biochem Mol Biol Int; 1993 Jan; 29(1):33-45. PubMed ID: 8490566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of animals with malignant tumors to experimental wound infection.
    Brin EN; Krizek TJ
    Surg Forum; 1974; 25(0):526-8. PubMed ID: 4439250
    [No Abstract]   [Full Text] [Related]  

  • 14. Walker 256 tumor MHC class I expression during the shift from A variant to the immunogenic AR variant.
    Schanoski AS; Cavalcanti TC; Campos CB; Viera-Matos AN; Rettori O; Guimarães F
    Cancer Lett; 2004 Jul; 211(1):119-27. PubMed ID: 15194224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the behavior of the spleen in animals with circulating neoplastic cells].
    Agostino D
    Osp Ital Chir; 1966; 14(5):553-7. PubMed ID: 5988956
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats.
    Kamocka M; Kaplinska K; Mielicki WP
    Clin Exp Med; 2006 Oct; 6(3):119-23. PubMed ID: 17061060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptance of Walker 256 carcinosarcoma by C57BL-6 mice treated with rabbit anti-mouse-thymus serum.
    Kubista TP; Shorter RG; Hallenbeck GA
    Cancer Res; 1967 Nov; 27(11):2072-6. PubMed ID: 6073502
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytokine gene expression in Walker 256: a comparison of variants A (aggressive) and AR (regressive).
    De Almeida Salles Perroud AP; Ashimine R; De Castro GM; Guimarães F; Vieira KP; Aparecida Vilella C; Samico Cavalcanti TC; De Lima Zollner R
    Cytokine; 2006 Nov; 36(3-4):123-33. PubMed ID: 17188888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of histocompatibility and biologically active serum factors between parental and filial generations of Wistar rats inoculated with Walker Carcinoma 256.
    Walker I
    Genetica; 1966; 37(3):427-39. PubMed ID: 5965032
    [No Abstract]   [Full Text] [Related]  

  • 20. Lifelong exposure to dietary fish oil alters macrophage responses in Walker 256 tumor-bearing rats.
    Bonatto SJ; Folador A; Aikawa J; Yamazaki RK; Pizatto N; Oliveira HH; Vecchi R; Curi R; Calder PC; Fernandes LC
    Cell Immunol; 2004; 231(1-2):56-62. PubMed ID: 15919370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.